IL-9 抗体
(Interleukin 9 (IL9))
The protein encoded by this gene is a cytokine that acts as a regulator of a variety of hematopoietic cells. This cytokine stimulates cell proliferation and prevents apoptosis. It functions through the interleukin 9 receptor (IL9R), which activates different signal transducer and activator (STAT) proteins and thus connects this cytokine to various biological processes. The gene encoding this cytokine has been identified as a candidate gene for asthma. Genetic studies on a mouse model of asthma demonstrated that this cytokine is a determining factor in the pathogenesis of bronchial hyperresponsiveness. [provided by RefSeq, Jul 2008].
| Catalog no. | 产品 | 适用 | 宿主 / 克隆类型 | 应用 | 价格和交货时间 |
|---|---|---|---|---|---|
| IL-9 抗体 (AA 21-120) (AbBy Fluor® 594) | 小鼠 | 兔 Polyclonal |
|
|
|
| IL-9 抗体 (AA 21-120) (AbBy Fluor® 488) | 小鼠 | 兔 Polyclonal |
|
|
|
| IL-9 抗体 (AA 21-120) (HRP) | 小鼠 | 兔 Polyclonal |
|
|
|
| IL-9 抗体 (AA 21-120) (Cy5.5) | 小鼠 | 兔 Polyclonal |
|
|
|
| IL-9 抗体 (AA 21-120) (Cy7) | 小鼠 | 兔 Polyclonal |
|
|
|
| IL-9 抗体 (AA 21-120) (FITC) | 小鼠 | 兔 Polyclonal |
|
|
|
| IL-9 抗体 (AA 1-144) | 人 | 兔 Polyclonal |
|
|
|
| IL-9 抗体 | 大鼠 | 绵羊 Polyclonal |
|
|
|
| Recombinant IL-9 抗体 | 小鼠 | 仓鼠 Monoclonal |
|
|
|
| Recombinant IL-9 抗体 | 小鼠 | 大鼠 Monoclonal |
|
|
|
| Recombinant IL-9 抗体 | 人 | 兔 Chimeric |
|
|
|
| Recombinant IL-9 抗体 | 人 | 小鼠 Monoclonal |
|
|
|
| Recombinant IL-9 抗体 | 小鼠 | 兔 Chimeric |
|
|
|
| Recombinant IL-9 抗体 | 小鼠 | 兔 Chimeric |
|
|
|
| IL-9 抗体 (C-Term) | 人 | 兔 Polyclonal |
|
|
|
| IL-9 抗体 | 人, 大鼠 | 兔 Polyclonal |
|
|
|
| IL-9 抗体 (AA 19-144) | 人 | 小鼠 Monoclonal |
|
|
|
| IL-9 抗体 | 小鼠 | 兔 Polyclonal |
|
|
|
| IL-9 抗体 | 人 | 兔 Polyclonal |
|
|
|
| IL-9 抗体 (AA 26-144) | 人 | 兔 Polyclonal |
|
|
Primary Antibody
- WB (Western Blotting: 所列应用)
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- 适用
- 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- AbBy Fluor® 594
- 抗体亚型
- IgG
- 抗原表位
- AA 21-120
Primary Antibody
- WB (Western Blotting: 所列应用)
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- 适用
- 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- AbBy Fluor® 488
- 抗体亚型
- IgG
- 抗原表位
- AA 21-120
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- IHC (fro) (Immunohistochemistry (Frozen Sections): 所列应用)
- 适用
- 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- HRP
- 抗体亚型
- IgG
- 抗原表位
- AA 21-120
Primary Antibody
- WB (Western Blotting: 所列应用)
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- 适用
- 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Cy5.5
- 抗体亚型
- IgG
- 抗原表位
- AA 21-120
Primary Antibody
- WB (Western Blotting: 所列应用)
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- 适用
- 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Cy7
- 抗体亚型
- IgG
- 抗原表位
- AA 21-120
Primary Antibody
- WB (Western Blotting: 所列应用)
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- 适用
- 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- FITC
- 抗体亚型
- IgG
- 抗原表位
- AA 21-120
Primary Antibody
- WB (Western Blotting: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 1-144
Primary Antibody
- FACS (Flow Cytometry: 所列应用)
- BP (Blocking Peptide: 所列应用)
- 适用
- 小鼠
- 宿主
- 仓鼠
- 克隆形成能力
- Monoclonal
- 克隆
- D9302C12
- 标记
- unconjugated
- 蛋白类型
- Recombinant Antibody
- 抗体亚型
- IgG, kappa
Primary Antibody
- ELISA (ELISA: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- 适用
- 小鼠
- 宿主
- 大鼠
- 克隆形成能力
- Monoclonal
- 克隆
- RM9A4
- 标记
- unconjugated
- 蛋白类型
- Recombinant Antibody
- 抗体亚型
- IgG1, kappa
Primary Antibody
- ELISA (ELISA: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Chimeric
- 克隆
- MH9A4
- 标记
- unconjugated
- 蛋白类型
- Recombinant Antibody
- 抗体亚型
- IgG, kappa
Primary Antibody
- ELISA (ELISA: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- MH9A4
- 标记
- unconjugated
- 蛋白类型
- Recombinant Antibody
- 抗体亚型
- IgG2b, kappa
Primary Antibody
- ELISA (ELISA: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- 适用
- 小鼠
- 宿主
- 兔
- 克隆形成能力
- Chimeric
- 克隆
- RM9A4
- 标记
- unconjugated
- 蛋白类型
- Recombinant Antibody
- 抗体亚型
- IgG, kappa
Primary Antibody
- FACS (Flow Cytometry: 所列应用)
- BP (Blocking Peptide: 所列应用)
- 适用
- 小鼠
- 宿主
- 兔
- 克隆形成能力
- Chimeric
- 克隆
- D9302C12
- 标记
- unconjugated
- 蛋白类型
- Recombinant Antibody
- 抗体亚型
- IgG, kappa
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- IF (Immunofluorescence: 所列应用)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- C-Term
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 8D11
- 标记
- unconjugated
- 抗体亚型
- IgG2a
- 抗原表位
- AA 19-144
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗原表位
- AA 26-144
Latest Publications for our IL-9 抗体
: "The Immunogenicity of Branded and Biosimilar Infliximab in Rheumatoid Arthritis According to Th9-Related Responses." in: International journal of molecular sciences, Vol. 18, Issue 10, (2017) (PubMed).
: "Interleukin-9 Is Associated with Elevated Anti-Double-Stranded DNA Antibodies in Lupus-Prone Mice." in: Molecular medicine (Cambridge, Mass.), Vol. 21, pp. 364-70, (2016) (PubMed).
: "Expression of interleukin-9 and its upstream stimulating factors in rats with ischemic stroke." in: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, (2015) (PubMed).
: "Targeting the binding interface on a shared receptor subunit of a cytokine family enables the inhibition of multiple member cytokines with selectable target spectrum." in: The Journal of biological chemistry, Vol. 290, Issue 37, pp. 22338-51, (2015) (PubMed).
: "Neutralization of interleukin-9 ameliorates symptoms of experimental autoimmune myasthenia gravis in rats by decreasing effector T cells and altering humoral responses." in: Immunology, Vol. 143, Issue 3, pp. 396-405, (2014) (PubMed).
: "Association analysis of polymorphisms in IL-3, IL-4, IL-5, IL-9, and IL-13 with Graves' disease." in: Journal of endocrinological investigation, Vol. 33, Issue 10, pp. 751-5, (2010) (PubMed).
: "Serum interleukin 9 in allergic rhinitis." in: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, Vol. 104, Issue 2, pp. 180-1, (2010) (PubMed).
: "Differential roles for the IL-9/IL-9 receptor alpha-chain pathway in systemic and oral antigen-induced anaphylaxis." in: The Journal of allergy and clinical immunology, Vol. 125, Issue 2, pp. 469-476.e2, (2010) (PubMed).
: "Immunoenzymetric assay of mouse and human cytokines using NIP-labeled anti-cytokine antibodies." in: Current protocols in immunology / edited by John E. Coligan ... [et al.], Vol. Chapter 6, pp. Unit 6.20, (2008) (PubMed).
: "New insights into the role of cytokines in asthma." in: Journal of clinical pathology, Vol. 54, Issue 8, pp. 577-89, (2001) (PubMed).
: "Interleukin-9 Is Associated with Elevated Anti-Double-Stranded DNA Antibodies in Lupus-Prone Mice." in: Molecular medicine (Cambridge, Mass.), Vol. 21, pp. 364-70, (2016) (PubMed).
: "Expression of interleukin-9 and its upstream stimulating factors in rats with ischemic stroke." in: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, (2015) (PubMed).
: "Targeting the binding interface on a shared receptor subunit of a cytokine family enables the inhibition of multiple member cytokines with selectable target spectrum." in: The Journal of biological chemistry, Vol. 290, Issue 37, pp. 22338-51, (2015) (PubMed).
: "Neutralization of interleukin-9 ameliorates symptoms of experimental autoimmune myasthenia gravis in rats by decreasing effector T cells and altering humoral responses." in: Immunology, Vol. 143, Issue 3, pp. 396-405, (2014) (PubMed).
: "Association analysis of polymorphisms in IL-3, IL-4, IL-5, IL-9, and IL-13 with Graves' disease." in: Journal of endocrinological investigation, Vol. 33, Issue 10, pp. 751-5, (2010) (PubMed).
: "Serum interleukin 9 in allergic rhinitis." in: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, Vol. 104, Issue 2, pp. 180-1, (2010) (PubMed).
: "Differential roles for the IL-9/IL-9 receptor alpha-chain pathway in systemic and oral antigen-induced anaphylaxis." in: The Journal of allergy and clinical immunology, Vol. 125, Issue 2, pp. 469-476.e2, (2010) (PubMed).
: "Immunoenzymetric assay of mouse and human cytokines using NIP-labeled anti-cytokine antibodies." in: Current protocols in immunology / edited by John E. Coligan ... [et al.], Vol. Chapter 6, pp. Unit 6.20, (2008) (PubMed).
: "New insights into the role of cytokines in asthma." in: Journal of clinical pathology, Vol. 54, Issue 8, pp. 577-89, (2001) (PubMed).
Aliases for IL-9 抗体
interleukin 9 (IL9) 抗体interleukin 9 (il9) 抗体
interleukin 9 (Il9) 抗体
HP40 抗体
IL-9 抗体
Il-9 抗体
IL9 抗体
P40 抗体
您还需要查找其他产品吗？
You are here:
